Literature DB >> 18215123

Role of a tryptophan anchor in human topoisomerase I structure, function and inhibition.

Gary S Laco1, Yves Pommier.   

Abstract

Human Top1 (topoisomerase I) relaxes supercoiled DNA during cell division and transcription. Top1 is composed of 765 amino acids and contains an unstructured N-terminal domain of 200 amino acids, and a structured functional domain of 565 amino acids that binds and relaxes supercoiled DNA. In the present study we examined the region spanning the junction of the N-terminal domain and functional domain (junction region). Analysis of several published Top1 structures revealed that three tryptophan residues formed a network of aromatic stacking interactions and electrostatic interactions that anchored the N-terminus of the functional domain to sub-domains containing the nose cone and active site. Mutation of the three tryptophan residues (Trp(203)/Trp(205)/Trp(206)) to an alanine residue, either individually or together, in silico revealed that the individual tryptophan residue's contribution to the tryptophan 'anchor' was additive. When the three tryptophan residues were mutated to alanine in vitro, the resulting mutant Top1 differed from wild-type Top1 in that it lacked processivity, exhibited resistance to camptothecin and was inactivated by urea. The results indicated that the tryptophan anchor stabilized the N-terminus of the functional domain and prevented the loss of Top1 structure and function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18215123      PMCID: PMC2692499          DOI: 10.1042/BJ20071436

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  The packing density in proteins: standard radii and volumes.

Authors:  J Tsai; R Taylor; C Chothia; M Gerstein
Journal:  J Mol Biol       Date:  1999-07-02       Impact factor: 5.469

2.  Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status.

Authors:  Yinghui Mao; Issac R Mehl; Mark T Muller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

3.  The mechanism of topoisomerase I poisoning by a camptothecin analog.

Authors:  Bart L Staker; Kathryn Hjerrild; Michael D Feese; Craig A Behnke; Alex B Burgin; Lance Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-08       Impact factor: 11.205

4.  Residues 190-210 of human topoisomerase I are required for enzyme activity in vivo but not in vitro.

Authors:  Morten O Christensen; Hans U Barthelmes; Fritz Boege; Christian Mielke
Journal:  Nucleic Acids Res       Date:  2003-12-15       Impact factor: 16.971

5.  The N-terminal domain anchors human topoisomerase I at fibrillar centers of nucleoli and nucleolar organizer regions of mitotic chromosomes.

Authors:  Morten O Christensen; Hans U Barthelmes; Fritz Boege; Christian Mielke
Journal:  J Biol Chem       Date:  2002-07-15       Impact factor: 5.157

Review 6.  Domains of human topoisomerase I and associated functions.

Authors:  J J Champoux
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1998

7.  A novel nuclear localization signal in human DNA topoisomerase I.

Authors:  Y Y Mo; C Wang; W T Beck
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

8.  Biochemical and biophysical analyses of recombinant forms of human topoisomerase I.

Authors:  L Stewart; G C Ireton; L H Parker; K R Madden; J J Champoux
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

9.  Role for nucleolin/Nsr1 in the cellular localization of topoisomerase I.

Authors:  T K Edwards; A Saleem; J A Shaman; T Dennis; C Gerigk; E Oliveros; M R Gartenberg; E H Rubin
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

10.  Rotation of DNA around intact strand in human topoisomerase I implies distinct mechanisms for positive and negative supercoil relaxation.

Authors:  Levent Sari; Ioan Andricioaei
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

View more
  11 in total

1.  RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription.

Authors:  Laura Baranello; Damian Wojtowicz; Kairong Cui; Ballachanda N Devaiah; Hye-Jung Chung; Ka Yim Chan-Salis; Rajarshi Guha; Kelli Wilson; Xiaohu Zhang; Hongliang Zhang; Jason Piotrowski; Craig J Thomas; Dinah S Singer; B Franklin Pugh; Yves Pommier; Teresa M Przytycka; Fedor Kouzine; Brian A Lewis; Keji Zhao; David Levens
Journal:  Cell       Date:  2016-04-07       Impact factor: 41.582

2.  A kinetic clutch governs religation by type IB topoisomerases and determines camptothecin sensitivity.

Authors:  Yeonee Seol; Hongliang Zhang; Yves Pommier; Keir C Neuman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-18       Impact factor: 11.205

3.  The Indenoisoquinoline LMP517: A Novel Antitumor Agent Targeting both TOP1 and TOP2.

Authors:  Laetitia Marzi; Yilun Sun; Shar-Yin N Huang; Amy James; Simone Difilippantonio; Yves Pommier
Journal:  Mol Cancer Ther       Date:  2020-05-19       Impact factor: 6.261

4.  DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin.

Authors:  Christine M Wright; Marié van der Merwe; Amanda H DeBrot; Mary-Ann Bjornsti
Journal:  J Biol Chem       Date:  2015-03-20       Impact factor: 5.157

5.  Swapping of The N-Terminal Domain of Human Topoisomerase 1B with the Corresponding Plasmodium Falciparum Counterpart Strongly Impairs Enzyme Activity.

Authors:  Jagadish Babu Dasari; Bini Chhetri Soren; Alessio Ottaviani; Cinzia Tesauro; Simona Marino; Beatrice Messina; Paola Fiorani
Journal:  Rep Biochem Mol Biol       Date:  2020-01

6.  Evaluation of two models for human topoisomerase I interaction with dsDNA and camptothecin derivatives.

Authors:  Gary S Laco
Journal:  PLoS One       Date:  2011-08-30       Impact factor: 3.240

7.  Sequence selectivity of the cleavage sites induced by topoisomerase I inhibitors: a molecular dynamics study.

Authors:  Fung-Ming Siu; Yves Pommier
Journal:  Nucleic Acids Res       Date:  2013-09-09       Impact factor: 16.971

8.  A conserved SUMO pathway repairs topoisomerase DNA-protein cross-links by engaging ubiquitin-mediated proteasomal degradation.

Authors:  Yilun Sun; Lisa M Miller Jenkins; Yijun P Su; Karin C Nitiss; John L Nitiss; Yves Pommier
Journal:  Sci Adv       Date:  2020-11-13       Impact factor: 14.136

9.  Adaptation of topoisomerase I paralogs to nuclear and mitochondrial DNA.

Authors:  Ilaria Dalla Rosa; Steffi Goffart; Melanie Wurm; Constanze Wiek; Frank Essmann; Stefan Sobek; Peter Schroeder; Hongliang Zhang; Jean Krutmann; Helmut Hanenberg; Klaus Schulze-Osthoff; Christian Mielke; Yves Pommier; Fritz Boege; Morten O Christensen
Journal:  Nucleic Acids Res       Date:  2009-08-31       Impact factor: 16.971

10.  Poly(ADP-ribose) polymers regulate DNA topoisomerase I (Top1) nuclear dynamics and camptothecin sensitivity in living cells.

Authors:  Subhendu K Das; Ishita Rehman; Arijit Ghosh; Souvik Sengupta; Papiya Majumdar; Biman Jana; Benu Brata Das
Journal:  Nucleic Acids Res       Date:  2016-07-27       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.